An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington's disease. (2017)

First Author: Underwood BR
Attributed to:  Confidence in Concept 2012 - Cambridge funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00415-017-8647-0

PubMed Identifier: 29075837

Publication URI: http://europepmc.org/abstract/MED/29075837

Type: Journal Article/Review

Volume: 264

Parent Publication: Journal of neurology

Issue: 12

ISSN: 0340-5354